t2cure
t2cure is dedicated to the development of novel progenitor cell-based regenerative therapeutics to provide new treatment options to patients suffering from cardiovascular diseases like myocardial infarction or peripheral vascular diseases.
Industries
biotechnology
genetics
health-care
therapeutics
Nr. of Employees
small (1-50)
Products
Regenerative Therapeutics
t2cure focuses on developing therapies based on progenitor cells derived from the patient's bone marrow to initiate tissue repair processes by improving blood flow and releasing messenger substances that favor cell regeneration.
Treatment for Cardiovascular Conditions
The company's cell-based therapies are aimed at patients with recent heart attacks, chronic heart failure, and general circulatory disorders, such as those affecting the leg arteries.
Regenerative Therapeutics
t2cure focuses on developing therapies based on progenitor cells derived from the patient's bone marrow to initiate tissue repair processes by improving blood flow and releasing messenger substances that favor cell regeneration.
Treatment for Cardiovascular Conditions
The company's cell-based therapies are aimed at patients with recent heart attacks, chronic heart failure, and general circulatory disorders, such as those affecting the leg arteries.